A pooled multicountry analysis shows that immunisation with nirsevimab effectively reduced RSV-related hospitalisation in children younger than 24 months during the 2024-2025 season.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/nirsevimab-offers-early-rsv-protection-european-children-2025a1000wc9?src=rss
Author :
Publish date : 2025-11-24 12:00:00
Copyright for syndicated content belongs to the linked Source.